| NDC Code | 63083-2128-2 |
|---|
| Package Description | 59 mL in 1 BOTTLE, DROPPER (63083-2128-2) |
|---|
| Product NDC | 63083-2128 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Lyme Nosode Drops |
|---|
| Proprietary Name Suffix | 2128 |
|---|
| Non-Proprietary Name | Lyme Nosode Drops |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19840815 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Professional Complementary Health Formulas |
|---|
| Substance Name | ANGELICA ARCHANGELICA ROOT; ANGELICA PUBESCENS ROOT; GAMBIR; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; MANGANESE; YUCCA FILAMENTOSA WHOLE; BOVINE TYPE II COLLAGEN (TRACHEAL CARTILAGE); PHYTOLACCA AMERICANA ROOT; GOLDENSEAL; TOXICODENDRON PUBESCENS LEAF; CAUSTICUM; LATIGLUTENASE; OXALIC ACID; ARNICA MONTANA WHOLE; LATRODECTUS MACTANS; BORRELIA BURGDORFERI; TREPONEMIC SKIN CANKER HUMAN; RICKETTSIA AKARI; BABESIA MICROTI; EHRLICHIA CHAFFEENSIS |
|---|
| Strength | 2; 2; 8; 12; 12; 3; 6; 12; 2; 5; 8; 10; 2; 3; 8; 4; 3; 12; 6; 12; 3 |
|---|
| Strength Unit | [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL |
|---|
| Pharmacy Classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|